Clinical Trials · NCT06267092
A Study of How CagriSema Works on Appetite in People With Excess Body Weight
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 164
- Start date
- Feb 2024
- Locations
- 1 site, Germany
- Primary endpoint
- Change in mean postprandial appetite score based on visual analogue scale (VAS)